نتائج البحث 121-130 من 11424 لعملية البحث عن ✏[광고텔레:TOOPPC] 웹문서작업업체 개인통장업체 백링크광고 상위노출광고 구글1페이지광고 카지노알광고 언더키워드대행 법인장구매 카지노커뮤니티 구글휴게텔홍보✏
... 1 of 6 standard of care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. The primary study hypothesis is that pembrolizumab ...
In the study, 122 patients will be randomized in a 1:1 ratio to receive doxorubicin treatment (Arm 1) or L19TNF treatment in combination with doxorubicin (Arm 2) ...
لن يقتصر دور Mayo Clinic على مجال الطب خلال رحلة السعي إلى تحقيق رؤيتنا. سنتعلم ونبتكر عند دمج الطب مع مجالات أخرى بخلاف علم الطب الحيوي وعلوم الحياة، مثل ...
Lymphoma is a diversified disease with outcomes differing upon the types and subtypes of lymphoma as well as treatment modalities used. Fertility outcomes in ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...
... 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed ...
In Part 2, the step-up dose identified in Part 1 will be used followed by the target dose of ABBV-383. Inotuzumab Ozogamicin and Frontline Chemotherapy in ...
Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ. Rochester, Minn. The purpose of this study is to analyze ...
Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide ...
Scottsdale/Phoenix, Ariz. The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.